{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:34:24Z","timestamp":1717803264289},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10840-017-0223-0","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T06:48:33Z","timestamp":1484549313000},"page":"261-266","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The gap between indicated and prescribed stroke prevention therapies in a high-risk geriatric population"],"prefix":"10.1007","volume":"48","author":[{"given":"Mohammed","family":"Shurrab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrishikesh","family":"Navare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Lashevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"223_CR1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","volume":"110","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042\u20136.","journal-title":"Circulation"},{"key":"223_CR2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","volume":"36","author":"C Marini","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke J Cereb Circ. 2005;36:1115\u20139.","journal-title":"Stroke J Cereb Circ"},{"key":"223_CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2014.09.092","volume":"177","author":"T Andersson","year":"2014","unstructured":"Andersson T, Magnuson A, Bryngelsson IL, Frobert O, Henriksson KM, Edvardsson N, et al. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol. 2014;177:91\u20139.","journal-title":"Int J Cardiol"},{"key":"223_CR4","doi-asserted-by":"crossref","unstructured":"Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.","DOI":"10.1136\/bmj.d124"},{"key":"223_CR5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cjca.2014.08.001","volume":"30","author":"A Verma","year":"2014","unstructured":"Verma A, Cairns JA, Mitchell LB, Macle L, Stiell IG, Gladstone D, et al. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2014;30:1114\u201330.","journal-title":"Can J Cardiol"},{"key":"223_CR6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.323.7323.1218","volume":"323","author":"PJ Devereaux","year":"2001","unstructured":"Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ. 2001;323:1218\u201322.","journal-title":"BMJ"},{"key":"223_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joim.12114","volume":"274","author":"L Friberg","year":"2013","unstructured":"Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J Intern Med. 2013;274:461\u20138.","journal-title":"J Intern Med"},{"key":"223_CR8","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1161\/STROKEAHA.114.006070","volume":"45","author":"L Friberg","year":"2014","unstructured":"Friberg L, Rosenqvist M, Lindgren A, Terent A, Norrving B, Asplund K. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke J Cereb Circ. 2014;45:2599\u2013605.","journal-title":"Stroke J Cereb Circ"},{"key":"223_CR9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"key":"223_CR10","doi-asserted-by":"crossref","unstructured":"You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e531S-75S.","DOI":"10.1378\/chest.141.4.1129b"},{"key":"223_CR11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacc.2012.03.019","volume":"60","author":"GY Lip","year":"2012","unstructured":"Lip GY, Larsen TB, Skjoth F, Rasmussen LH. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2012;60:738\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"223_CR12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955\u201362.","journal-title":"Lancet"},{"key":"223_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ageing\/afv156","volume":"45","author":"KH Ng","year":"2016","unstructured":"Ng KH, Shestakovska O, Connolly SJ, Eikelboom JW, Avezum A, Diaz R, et al. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age Ageing. 2016;45:77\u201383.","journal-title":"Age Ageing"},{"key":"223_CR14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cjca.2015.07.012","volume":"32","author":"P Angaran","year":"2016","unstructured":"Angaran P, Dorian P, Tan MK, Kerr CR, Green MS, Gladstone DJ, et al. The risk stratification and stroke prevention therapy care gap in Canadian atrial fibrillation patients. Can J Cardiol. 2016;32:336\u201343.","journal-title":"Can J Cardiol"},{"key":"223_CR15","first-page":"1328","volume":"75","author":"H Atarashi","year":"2011","unstructured":"Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H, et al. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM registry. Circ J Offic J Japan Circ Soc. 2011;75:1328\u201333.","journal-title":"Circ J Offic J Japan Circ Soc"},{"key":"223_CR16","doi-asserted-by":"crossref","unstructured":"Hsu JCMTMKKF, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, et al. Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk insights from the NCDR PINNACLE registry. JAMA Cardiol. 2016.","DOI":"10.1001\/jamacardio.2015.0374"},{"key":"223_CR17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2125.2007.02954.x","volume":"64","author":"A Mahmud","year":"2007","unstructured":"Mahmud A, Bennett K, Okechukwu I, Feely J. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing. Br J Clin Pharmacol. 2007;64:706\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"17","key":"223_CR18","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.jacc.2011.07.028","volume":"58","author":"FA McAlister","year":"2011","unstructured":"McAlister FA. The end of the risk\u2013treatment paradox? A rising tide lifts all boats. JACC. 2011;58(17):1766\u20137.","journal-title":"JACC"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-017-0223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-017-0223-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-017-0223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T15:46:20Z","timestamp":1568735180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-017-0223-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1007\/s10840-017-0223-0","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}